Glimip MP 1mg/500mg/15mg Tablet
By Glimip MP
Rx
10 Tablet in a Strip

Composition
Glimepiride(1mg) + Metformin(500mg) + Pioglitazone(15mg)

Manufacturer - Roussel Laboratories Pvt Ltd
godown no. b/19 part-2, gujrat estate sarkhej sanand road, sarkhej ahmedabad ahmedabad gj 382210 in

Expires on or after
July, 2026

liver
When using Glimip MP 1mg/500mg/15mg Tablet, it is important to exercise caution if you have liver disease. Patients with liver issues may require a dose adjustment when taking Glimip MP 1mg/500mg/15mg Tablet. It is crucial to consult your doctor before using this medication, especially if you have any liver conditions. It is not advisable to use Glimip MP 1mg/500mg/15mg Tablet if you have severe liver disease. Always seek guidance from your healthcare provider regarding the use of this medication for your safety.

kidney
Caution Glimip MP 1mg/500mg/15mg Tablet may require dose adjustment for patients with kidney disease. Avoid use in severe kidney disease. Regular kidney function tests are recommended. Consult your doctor for proper guidance before using Glimip MP 1mg/500mg/15mg Tablet.

alcohol
It is not safe to drink alcohol while taking Glimip MP 1mg/500mg/15mg Tablet.

driving
If you experience low or high blood sugar, avoid driving while taking Glimip MP 1mg/500mg/15mg Tablet. Be cautious and refrain from driving if these symptoms occur.

pregnancy
Glimip MP 1mg/500mg/15mg Tablet may not be safe during pregnancy. Limited human studies indicate potential harm to the baby, as seen in animal studies. Consult your doctor to discuss benefits and risks.

breastfeeding
Caution is advised when breastfeeding while using Glimip MP 1mg/500mg/15mg Tablet as it may be unsafe. Limited data shows the drug could potentially pass into breastmilk and harm the baby.
| Habit Forming | No |
| Chemical Class | - |
| Therapeutic Class | ANTI DIABETIC |
| Action Class | - |
₹66
Inclusive of all taxes
Content verified by

Dr. Preeti Kumar
MBBS, DGO - Obstetrics and Gynaecology, DNB - Obstetrics and Gynaecology
Last update on 01-Oct-2024
